Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autolus Therapeutics PLC

2.34
+0.08003.54%
Post-market: 2.32-0.0200-0.85%18:49 EDT
Volume:2.65M
Turnover:6.26M
Market Cap:622.77M
PE:-2.62
High:2.43
Open:2.28
Low:2.28
Close:2.26
Loading ...

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

MT Newswires Live
·
06 May

Autolus Therapeutics PLC expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
06 May

European Equities Traded in the US as American Depositary Receipts Jump in Friday Trading

MT Newswires Live
·
02 May

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading

MT Newswires Live
·
28 Apr

Autolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRA

TipRanks
·
27 Apr

Autolus Gets Conditional Marketing Authorization for Aucatzyl to Treat Relapsed Leukemia

MT Newswires Live
·
26 Apr

Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event

GlobeNewswire
·
24 Apr

Autolus Therapeutics to Present R&D Update April 23

TIPRANKS
·
23 Apr

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
17 Apr

April 2025's Top Penny Stocks To Watch

Simply Wall St.
·
16 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Autolus Therapeutics Plc : Truist Securities Cuts Target Price to $10 From $11

THOMSON REUTERS
·
01 Apr

Truist Adjusts Price Target on Autolus Therapeutics to $10 From $11, Maintains Buy Rating

MT Newswires Live
·
31 Mar

Wells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)

TIPRANKS
·
21 Mar

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs

GuruFocus.com
·
21 Mar

Q4 2024 Autolus Therapeutics PLC Earnings Call

Thomson Reuters StreetEvents
·
21 Mar

Stock Track | Autolus Therapeutics Surges 5.07% After-Hours on Strong 2024 Results and AUCATZYL Launch Success

Stock Track
·
21 Mar

Stock Track | Autolus Therapeutics Plummets 5.15% on Wider Q4 Loss and Increased Annual Expenses

Stock Track
·
20 Mar